BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x June 30, 2010

[FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [LABORNTRACT Party A: Shaanxi Aoxing Pharmaceuticaldress: Chenyangzhai, Xianyang Legal Representative: Ronghua Wang Party B: Ronghua Wangdress: Shenjia Xiaoqu, Floor 21, Room 3103, Qindu District, Xiayang ID number: xxxxxxxxxxxxxxx Parties Party A and Party B (the I. Term of Employment 1.reement Part Arees to employ Party B and enter into this laborntract (the] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION I, Deyin Chen, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 5 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Deyin Chen Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 6 EX-32.2]

By | 2016-02-07T17:18:12+00:00 August 13th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar. His expertise includes financial management, financing transactions, corporate governance and investor relations. Most recently, Mr. Chen was an independent advisor engaged in local RMB PE fundraising and providing M&A and]

By | 2016-03-03T14:14:31+00:00 July 6th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. APPOINTS NEW CHIEF FINANCIAL OFFICER

[BIOSTAR PHARMACEUTICALS, INC. APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar. His expertise includes financial management, financing transactions, corporate governance and investor relations. Most recently, Mr. Chen was an independent advisor engaged in local RMB PE fundraising and providing M&A and]

By | 2016-03-03T14:16:41+00:00 July 6th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar.His expertiseludes financial management, financing transactions,rporate governance and investor relations.Most recently, Mr. Chen was an independentvisor engaged in local RMB PE fundraising and providing M&A and PEvisory]

By | 2016-02-07T17:19:11+00:00 July 6th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG,

[BIOSTAR PHARMACEUTICALS, APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar.His expertiseludes financial management, financing transactions,rporate governance and investor relations.Most recently, Mr. Chen was an independentvisor engaged in local RMB PE fundraising and providing M&A and PEvisory]

By | 2016-02-07T17:20:09+00:00 July 6th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT 陈德胤 W I T N E S S E T H: WHEREAS WHEREAS NOW, THEREFORE 1. Employment of Chief Financial Officer of the Company . 2. Term 3. Duties . 4. Compensation . a. (i) Executive shall be paid a base pay of RMB 50,000 per month during the Term, payable on the last day]

By | 2016-03-03T14:18:31+00:00 July 2nd, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT 陈德胤 W I

[EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT 陈德胤 W I T N E S S E T H: WHEREAS WHEREAS NOW, THEREFORE 1. Employment of Chief Financial Officer of the Company . 2. Term 3. Duties . 4. Compensation . a. (i) Executive shall be paid a base pay of RMB 50,000 per month during the Term, payable on the last day]

By | 2016-03-03T14:20:07+00:00 July 2nd, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: EMPLOYMENTREEMENT THIS EMPLOYMENTREEMENT W I T N E

[EMPLOYMENTREEMENT THIS EMPLOYMENTREEMENT W I T N E S S E T H: WHEREAS WHEREAS NOW, THEREFORE 1. Employment of Chief Financial Officer of thempany . 2. Term 4.mpensation . a.(i)Executive shall be paid a base pay of RMB 50,000 per month during the Term, payable on the lasty of each month.]

By | 2016-02-07T17:22:04+00:00 July 2nd, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[EMPLOYMENTREEMENT THIS EMPLOYMENTREEMENT W I T N E S S E T H: WHEREAS WHEREAS NOW, THEREFORE 1. Employment of Chief Financial Officer of thempany . 2. Term 4.mpensation . a.(i)Executive shall be paid a base pay of RMB 50,000 per month during the Term, payable on the lasty of each month.]

By | 2016-02-07T17:21:07+00:00 July 2nd, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line Increases overall capacity by $30 million annually and paves way for entrance into the Military Pharmaceutical Market XIANYANG, China, May 25, 2010 (Xinhua-PRNewswire-FirstCall) BSPM News Biostar completed Chinese Military Drug Administration clinical trials for Zushima Analgesic Aerosol Spray (“Zushima”) in April through the Chinese No. 4 Military Medical University. Zushima is]

By | 2016-03-03T14:22:20+00:00 May 25th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar